Skip to content

A STUDY TO COMPARE THE EFFECTIVENESS AND SAFETY OF GIVING ROCURONIUM PRIOR TO SUCCINYLCHOLINE TO ASSESS SUCCINYLCHOLINE INDUCED FASCICULATIONS AND MUSCULAR PAIN

A COMPARATIVE STUDY TO ASSESS THE EFFICACY AND SAFETY OF ROCURONIUM PRETREATMENT ON SUCCINYLCHOLINE INDUCED FASCICULATIONS AND MYALGIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046136
Enrollment
40
Registered
2022-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 2: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 3: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere

Interventions

Intervention1: Group I: Patients will receive single dose of Rocuronium 0.06 mg/kg diluted to 2ml intravenously: Group II: Patients will receive single dose of normal saline of 2ml intravenously Inte

Sponsors

Department of Anaesthesia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient scheduled under general anaesthesia for elective surgery, MPG I and II, Asa I and II

Exclusion criteria

Exclusion criteria: 1 Patients with comorbidity 2 ASA III and IV 3 MPG III and IV (difficult airway) 4 Age 60 years

Design outcomes

Primary

MeasureTime frame
To evaluate the pretreatment with rocuronium in preventing fasciculation caused by succinylcholine in patient posted for surgery under general anaesthesia.Timepoint: Intra operative period

Secondary

MeasureTime frame
To evaluate the efficacy of rocuronium pre-treatment in preventing postoperative myalgia in post anesthesia care unit and myalgia at 24 hours in patients undergoing elective surgery.Timepoint: Post operative period

Countries

India

Contacts

Public ContactSapna Bansal

MM Institute of Medical Sciences

drsapna10@gmail.com08168381441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026